For the quarter ending 2025-12-31, CVAT has $55K in assets. $303K in debts. $31K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 31 | 30 | 249 | |
| Accounts receivable | 0 | 5 | 10 | |
| Prepaid expenses | 13 | 14 | 27 | |
| Total current assets | 44 | 49 | 286 | |
| Equity method investment | - | - | 1 | |
| Operating lease right-of-use asset | - | - | 0 | |
| Other assets | 11 | 11 | 10 | |
| Total assets | 55 | 60 | 297 | |
| Accounts payable and accrued expenses | 143 | 99 | 93 | |
| Accrued payroll and payroll taxes related parties | - | - | 0 | |
| Notes payable | - | - | 9 | |
| Convertible note payable, net of discount | 3 | - | - | |
| Operating lease liability, current portion | - | - | 0 | |
| Derivative liability | 7 | - | - | |
| Total current liabilities | 153 | 99 | 102 | |
| Note payable, non-current | 150 | 150 | 126 | |
| Total liabilities | 303 | 249 | 228 | |
| Common stock, 0.001par value, 1,000,000,000 shares authorized, 309,720,740 and 289,156,340 shares issued and outstanding as of december 31, 2025 and june 30, 2025, respectively | 310 | 289 | 289 | |
| Additional paid-in capital | 27,136 | 26,740 | 26,740 | |
| Accumulated deficit | -27,694 | -27,218 | -26,960 | |
| Total stockholders' equity (deficit) | -248 | -189 | 69 | |
| Total liabilities and stockholders' equity (deficit) | 55 | 60 | 297 | |
Cavitation Technologies, Inc. (CVAT)
Cavitation Technologies, Inc. (CVAT)